Clinical features and treatment outcome of idiopathic membranous nephropathy in Chinese patients

QJM: An International Journal of Medicine

Volumn 92, Issue 7, 1999, Pages 401-406

  Tang, S ^a   Chan, T M ^b   Cheng, I K P ^b   Lai, K N ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; CREATINE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISOLONE; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CAUCASIAN; CHINESE; CLINICAL ARTICLE; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; REMISSION; TREATMENT OUTCOME;

EID: 0032806194     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/92.7.401     Document Type: Article

References (16)

1. Honkanen E, Tornroth T, Gronhagen-Riska C. Natural history, clinical course and morphological evolution of membranous nephropathy. Nephrol Dial Transplant 1992; 7:35-41.
2. Honkanen E. Survival in idiopathic membranous glomerulonephritis. Clin Nephrol 1986; 25:122-8.
3. Murphy BF, Fairley KF, Kincaid-Smith PS. Idiopathic membranous glomerulonephritis: long-term follow-up in 139 cases. Clin Nephrol 1988; 30:175-81.
4. Davison AM, Cameron JS, Kerr DN, Ogg CS, Wilkinson RW. The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 1984; 22:61-7.
5. Zucchelli P, Ponticelli C, Cagnoli L, Passerini P, Long-term outcome of idiopathic membranous nephropathy with nephrotic syndrome. Nephrol Dial Transplant 1987; 2:73-8.
6. Couchoud C, Laville M, Boissel JP. Treatment of membranous nephropathy: a meta-analysis. Nephrol Dial Transplant 1994; 9:469-70.
7. Ponticelli C, Zucchelli P, Passerini P, et al. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1989; 320:8-13.
8. Wasserstein AG. Membranous glomerulonephritis. J Am Soc Nephrol 1997; 8:664-73.
9. O'Callaghan CA, Cameron JS, Sacks SH. Early prediction of treatment outcome in idiopathic membranous nephropathy. Q J Med 1995; 88:889-94.
10. Leung NW. Patterns of viral hepatitis in Hong Kong. Br J Hosp Med 1997; 58:166-9.
11. Cattran DC, Delmore T, Roscoe J, et al. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 1989; 320:210-15.
12. Cameron JS, Healy MJ, Adu D. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party. Q J Med 1990; 74:133-56.
13. Cattran DC, Pei Y, Greenwood CM, Ponticelli C, Passerini P, Honkanen E. Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int 1997; 51:901-7.
14. Sagripanti A, Barsotti G. Hypercoagulability, intraglomerular coagulation, and thromboembolism in nephrotic syndrome. Nephron 1995; 70:271-81.
15. Yu CM, Chan TY, Tsoi WC, Sanderson JE. Heparin therapy in the Chinese-lower doses are required. Q J Med 1997; 90:535-43.
16. Yu HC, Chan TY, Critchley JA, Woo KS. Factors determining the maintenance dose of warfarin in Chinese patients. Q J Med 1996; 89:127-35.